TT Patents & Techno Offers

15 % of the CSIC European patents applied in 2019 are from the ICMAB

In 2019 the ICMAB applied for 4 priority patent applications, all of them European, and for an extension in Europe of a French priority patent. This means that from the 34 European patent applications from the CSIC, 5 are from the ICMAB (nearly 15 %). The CSIC leads the European patents applied in Spain, and there is a new record of European patent applications from Spanish origin according to the 2019 Patent Index of the European Patent Office (EPO). 

TT Patents & Techno Offers, 2020

  • Hits: 809

New patent on magnetic resonance imaging (MRI) contrast agents based on organic metal-free dendrimers

Magnetic resonance imaging (MRI) is a commonly used clinical imaging technique for noninvasive diagnosis and characterization of soft tissues. The technique provides images in excellent detail of tumors and related pathological conditions thanks to the contrast agents used in the procedure. Now, a group of researchers from the ICMAB led by José Vidal-Gancedo, from the Nanomol Group, have developed organic metal-free magnetic resonance imaging (MRI) contrast agents based on dendrimers with a totally innovative synthesis procedure.

TT Patents & Techno Offers, 2020

  • Hits: 1086

More

Also on ICMAB...


INSTITUT DE CIÈNCIA DE MATERIALS DE BARCELONA, Copyright © 2020 ICMAB-CSIC | Privacy Policy | This email address is being protected from spambots. You need JavaScript enabled to view it.